Начало › Рак на яйчниците › Колорадо › Aurora
Клинични проучвания за Рак на яйчниците в Aurora, CO
25 проучвания за Рак на яйчниците търсят участници в обекти в и около Aurora (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Набиране на участнициФаза 2/3
- UCHealth University of Colorado Hospital, Aurora
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набиране на участнициФаза 2
- UCHealth University of Colorado Hospital, Aurora
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Набиране на участнициФаза 1/2
- Research Site, Aurora
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Набиране на участнициФаза 2
- University of Colorado Hospital- Aurora /ID# 278232, Aurora
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Набиране на участнициФаза 1/2
- University of Colorado Denver, Aurora
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Набиране на участнициФаза 3
- Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- University of Colorado Cancer Center, Aurora
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набиране на участнициФаза 1
- University of Colorado Cancer Center, Aurora
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Набиране на участнициФаза 3
- University of Colorado Cancer Center, Aurora
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Набиране на участнициНаблюдателно проучване
- University of Colorado, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Набиране на участнициФаза 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Набиране на участнициФаза 1/2
- Children's Hospital Colorado, Aurora
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Набиране на участници
- UCHealth University of Colorado Hospital, Aurora
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Набиране на участнициФаза 3
- UCHealth University of Colorado Hospital, Aurora
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
Набиране на участнициФаза 1
- CU Medicine Clinics, Aurora
- Universtiy of Colorado Hospital, Aurora
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Набиране на участнициФаза 2
- University of Colorado Hospital, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- University of Colorado Cancer Center, Aurora
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
Набиране на участници
- University of Colorado Anschutz Medical Campus, Aurora
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Набиране на участнициФаза 1/2
- University of Colorado, Anschutz Medical Campus, Aurora
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Набиране на участнициФаза 3
- University of Colorado Hospital - Anshutz Cancer Pavilion, Aurora
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Набиране на участници
- University of Colorado Cancer Center-Anschutz, Aurora
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Набиране на участнициФаза 1
- Site 0264, Aurora
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
Набиране на участнициФаза 1
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Aurora
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
Набиране на участници
- University of Colorado, Aurora
Проучвания за Рак на яйчниците в други градове
- Houston, TX89 проучвания
- New York City, NY69 проучвания
- Boston, MA61 проучвания
- Los Angeles, CA50 проучвания
- Nashville, TN49 проучвания
- Arlington, VA46 проучвания
- Philadelphia, PA44 проучвания
- Columbus, OH39 проучвания
- St. Louis, MO38 проучвания
- Chicago, IL36 проучвания
- San Antonio, TX31 проучвания
- Cleveland, OH30 проучвания
Други проучвания в Aurora
- Рак (всички видове)35 проучвания
- Колоректален рак32 проучвания
- Рак на белия дроб с недребноклетъчен тип31 проучвания
- Рак на гърдата28 проучвания
- Метастатичен рак25 проучвания
- Диабет тип 123 проучвания
- Затлъстяване22 проучвания
- Рак на простатата19 проучвания
- Рак на белия дроб19 проучвания
- Сърдечна недостатъчност18 проучвания
- Меланом18 проучвания
- Остра миелоидна левкемия16 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.